Health
Remdesivir may only provide modest benefit against ‘moderate’ COVID-19 – Medical Xpress
(HealthDay)—The antiviral drug remdesivir has been one of the few treatments that’s seemed to help curb death rates in COVID-19 patients so ill that they need a ventilator.
by E.j. Mundell, Healthday Reporter (HealthDay)The antiviral drug remdesivir has been one of the few treatments that’s seemed to help curb death rates in COVID-19 patients so ill that they need a ventilator.
But a new study finds the drug might not be as effective for ‘moderate’ cases of COVID-19patients hospitalized and perhaps needing oxygen to breathe, but not requiring a ventilator.
The study of nearly 600 such patients found that those who got a five-day course of remdesivir had a “statis…
Continue Reading
